New combo therapy shows promise for untreatable liver cancer
NCT ID NCT07281664
First seen Jan 05, 2026 · Last updated May 16, 2026 · Updated 19 times
Summary
This study tests a new first-line treatment for people with advanced liver cancer that cannot be removed by surgery. The treatment combines a procedure that delivers chemotherapy directly to the tumor (TACE) with two drugs that boost the immune system and block blood vessel growth. The goal is to see if this combination can shrink tumors and help patients live longer. About 30 adults aged 18 to 75 with good liver function will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.